The influenza A/Alaska/77 (H3N2) virus mutant 143-1 is temperature sensitive (ts) due to a spontaneous in-frame 36-nucleotide deletion in the nonstructural (NS) gene segment, which leads to a 12-amino-acid deletion in the NS1 protein. In addition, it has a small-plaque phenotype on MDCK cell monolayers. However, phenotypically revertant (i.e., ts+) viruses were isolated readily following replication of the 143-1 virus both in vitro and in vivo. In order to determine the genetic mechanism by which escape from the ts phenotype occurred, we performed segregational analysis and found that an intrasegmental suppressor mutation caused the loss of the ts phenotype. Nucleotide sequence analysis revealed the presence of an intragenic mutation in each of the ts+ phenotypic revertant viruses, involving a substitution of valine for alanine at amino acid 23 of the NS1 protein. This mutation resulted in acquisition of the ts+ phenotype and also in the large-plaque phenotype on MDCK cells, characteristic of the wild-type A/Alaska/77 parent virus. This amino acid substitution is predicted to generate an area of alpha helix in the secondary structure of the amino-terminal portion of the NS1 protein of the revertant viruses which may compensate for loss of an alpha-helical region due to the deletion of amino acids 66 to 77 in the NS1 protein of the 143-1 virus.
The genome of influenza A virus consists of eight segments of single-stranded negative-sense RNA encoding at least 10 viral polypeptides (11) . The NS gene -segment is the smallest of these gene segments and encodes two polypeptides found in infected cells but not in purified virions, referred to as NS1 and NS2. Few temperature-sensitive (ts) or conditionally lethal mutations of the NS gene segment are available, and relatively little is known regarding the roles of the NS1 and NS2 proteins in influenza virus replication.
Recently, an influenza A virus with an unusual NS gene segment was isolated during reassortment between the coldadapted (ca) influenza A/Ann Arbor/6/60 virus and the wild-type (wt) influenza A/Alaska/77 (H3N2) virus (13) . The reassortant virus, denoted CR43-3, derived the hemagglutinin (HA) and neuraminidase (NA) gene segments from the influenza A/Alaska/77 virus and the PB1, PB2, PA, nucleoprotein (NP), and matrix protein (M) gene segments from the ca influenza A/Ann Arbor/60 virus, but the NS gene segment did not appear to be derived from either parent virus. Nucleotide sequence analysis subsequently demonstrated that the NS gene segment of the CR43-3 virus was derived from that of the A/AlaskaI77 virus by an in-frame 36-nucleotide deletion, which led to a predicted deletion of amino acids 66 to 77 of the NS1 protein (2) . The CR43-3 virus was ts, with a shutoff temperature for plaque formation of 37°C, and manifested a host range phenotype not seen with either parent virus, characterized by restricted replication in Madin-Darby canine kidney (MDCK) cells compared with replication in primary chick kidney (PCK) cells (13) .
In order to evaluate specifically the contribution of the NS deletion to the phenotypes of the CR43-3 virus, a backcross mating of this virus with the A/Alaska/77 wt virus was performed (23) . Reassortant virus 143-1 was isolated, which derived the NS gene segment bearing the deletion mutation from the CR43-3 virus and all other gene segments from the * Corresponding author.
A/Alaska/77 wt virus. The 143-1 virus was ts, with a shutoff temperature for plaque formation of 37°C, but had only a partial-host-range phenotype, manifested by a reduction in the size of the plaques formed on MDCK cells. These phenotypes could also be transferred with the NS gene segment from the 143-1 virus to the wt influenza A/Bethesda/85 virus (23) .
The significant degree of temperature sensitivity associated with the deletion in the NS gene segment of the 143-1 virus suggested that this gene segment could be used as a genetically stable component of a live attenuated influenza virus vaccine. Therefore, further studies to evaluate the 143-1 virus in animals with a 37°C body temperature were performed. However, the 143-1 virus replicated efficiently in hamsters and chimpanzees, suggesting that the ts phenotype of this virus was host dependent (23) . In addition, viruses which had recovered the ability to grow in MDCK cells at 40°C (i.e., ts+ viruses) were isolated from these animals, suggesting that the defect in replication imposed by the NS deletion could be compensated for, most likely by one or more second-site mutations (23) . Analysis of such mutations may provide insight into the structural rTequirements for NS gene function or into possible interactions with other gene products. Therefore, in the current study, we determined the nucleotide sequence of the NS gene segment of the 143-1 virus and analyzed the mechanisms by which the ts phenotype of the 143-1 virus was lost during in vivo and in vitro passage. The results of these studies suggest that the ts and plaque-size phenotypes of the 143-1 virus can be directly attributed to the deletion in the NS gene and that loss of these phenotypes can occur by intragenic suppression by a point mutation.
taining the NS gene segment bearing the deletion mutation have been described previously (21, 23 (23) . In order to determine the mechanism by which these viruses escaped from the temperature-sensitive phenotype specified by the NS1 deletion mutation, three of the viruses isolated from animals were selected for further study and their shutoff temperature was determined after biological cloning. These results are shown in Table 1 errors at any specific site would be expected to constitute minor subpopulations of the bulk product. Each mutation was confirmed by sequencing of templates generated by at least two different PCR amplifications of virion RNA.
The nucleotide sequence of the NS gene segment of the 143-1 virus was identical to that of the A/Alaska/77 virus except for the 36-nucleotide deletion, confirming that additional mutations in the NS gene had not been selected in the generation of reassortant 143-1. The nucleotide sequence of the NS gene segment of the ts C1332-8 virus was identical to that of the 143-1 virus. However, the nucleotide sequences of the NS gene segments of the ts+ C1331-5, H2-7, and P4-40 viruses each contained a U to C transition at nucleotide 94 (mRNA sense), leading to a predicted change from valine to alanine at amino acid 23 of NS1. Because this change occurs within the NS2 intron, no alteration in NS2 would be predicted to occur. The mechanism of escape of these viruses from the ts phenotype was therefore attributable to intragenic suppression. The C1331-5 virus also had a noncoding nucleotide change from U to C at nucleotide 110. The sequences of the NS genes of the C1331-5, H2-7, and P4-40 viruses were otherwise identical to that of the 143-1 virus. In order to determine when in the course of serial in vitro passage of the P4-40 virus the U to C change at nucleotide 94 occurred, we determined the nucleotide sequence of the NS gene segment from nucleotides 50 to 150 of viruses from each passage level. As shown in Fig. 2 , the change from valine to alanine occurred between passage 2 and passage 3 of this virus, coincident with a significant change in shutoff temperature for plaque formation from 39 to more than 40°C. This change was seen more clearly after further passage and biological cloning of this virus.
The potential structural consequences of the amino acid change present in the revertant viruses, as predicted by computer analysis of secondary structure (6) , are shown in Fig. 3 . The 12-amino-acid deletion in the NS1 protein of the 143-1 virus disrupts a region of alpha helix predicted to occur approximately between amino acids 51 and 84 of the wildtype NS1 protein. The change from valine to alanine at amino acid 23 in the revertant viruses is predicted to result in generation of a new region of alpha helix between approximately amino acids 18 and 27 of the NS1 protein. The effects of these changes on the three-dimensional structure of the NS1 protein are unknown.
DISCUSSION
In a previous study, the 143-1 virus was shown to have two phenotypes which could be transferred with the NS gene segment to a wt influenza A virus, a shutoff temperature for plaque formation on MDCK cells of 37°C (ts phenotype) and a small-plaque phenotype on MDCK cells (23) . In the current study, we confirmed the ability of the NS gene (18, 26) , as has intragenic suppression of i's and other mutations of animal viruses, including vesicular stomatitis virus, poliovirus, foot-and-mouth disease virus, vaccinia virus, and Sindbis virus (12, 14, 17) . Intragenic suppression of a deletion mutation of an influenza virus has not been reported previously.
The mechanism by which this mutation affects the stability of the NS1 protein is unclear. The (20) . However, the presence of a valine at amino acid 23 of the NS1 protein is not conserved within human influenza A viruses (3) , suggesting that the structure of this particular region may tolerate some variability. While the change to alanine is a conservative one, computer analysis predicts that this substitution would result in conversion of a region of beta-sheet structure to one of alpha helix, approximately from amino acids 18 to 27 of NS1. It is therefore possible that this new region of alpha helix is able to substitute for the loss of the original alpha-helical structure. However, more definitive analysis of the functional significance of these mutations awaits the development of a direct in vitro assay of NS protein function.
The observation that a single point mutation may result in the loss of a phenotype specified by a deletion mutation is relevant to the development of live virus vaccines. Animal viruses bearing a number of types of missense mutations, including ts, ca, monoclonal antibody-resistant (mar), and protease activation (pa) mutations have been evaluated as potential live attenuated vaccines. In the case of the ts, mar, and pa mutants, reversion to the wild-type phenotype following replication in vitro or in vivo has been observed (5, 16, 28) , and this possibility represents a major concern in the use of missense mutations in the construction of such vaccines. This has been particularly true in the development of ts influenza A viruses as live virus vaccines, where phenotypic reversion of a ts influenza A virus containing two independent ts lesions was observed following prolonged replication in a seronegative child (25, 26) . To date, reversion of influenza virus vaccines containing the attenuating genes of the ca influenza A/Ann Arbor/6/60 virus has not been observed, possibly because this virus possesses four independent attenuating mutations (22) .
Viable animal viruses bearing large deletions represent an attractive alternative to missense mutations in the construction of live attenuated vaccines, since the attenuation phenotype imposed by such mutations should be more stable (15) . In addition, the recent development of techniques for in vitro mutagenesis of influenza A viruses provides a means for the ready construction of such mutations (7) . The results of the current study, however, suggest that even this approach will not eliminate the need for concern about possible reversion, since both intragenic and potentially extragenic suppressor mutations may develop and alter the phenotypes specified by deletion mutations. A similar need for concern has been suggested by the observation that second-site mutations in the simian virus 40 VP1 gene can suppress a large deletion in the agnogene of this virus following replication in vitro (1) . Therefore, it may be necessary to construct influenza viruses bearing deletion mutations in several gene segments to ensure adequate genetic stability. Studies to address the feasibility of this approach are in progress.
